Advertisement
Advertisement

SEPN

SEPN logo

Septerna, Inc. Common Stock

24.75
USD
Sponsored
-0.09
-0.36%
May 13, 15:59 UTC -4
Closed
exchange

Pre-Market

25.38

+0.63
+2.53%

Septerna, Inc. Common Stock Profile

About

Septerna Inc. is a clinical-stage biotechnology company pioneering a new era of GPCR oral small molecule drug discovery powered by its proprietary Native Complex Platform(TM). Septerna Inc. is based in SOUTH SAN FRANCISCO, Calif.

Info & Links

CEO

Jeffrey Finer

Headquarters

250 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://septerna.com

Auditor

Ernst & Young LLP

Share holders

60

Employees

130

Septerna, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.14B

Enterprise Value

1.07B

Enterprise Value/EBITDA(ttm)

-19.84

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

24.27

Price to Book(mrq)

2.91

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-133.57%

Profit Margin(ttm)

-7671.29%

Return on Equity(ttm)

-15.85%

Return on Invested Capital(ttm)

-12.65%

Return on Assets(ttm)

-11.96%

Income Statement

Revenue(ttm)

72.25M

Revenue Per Share(ttm)

1.60

Gross Profit(ttm)

72.25M

EBITDA(ttm)3

-54.06M

Net Income Available to Common(ttm)

-36.04M

Diluted EPS(ttm)

-1.11

Share Statistics

Beta (5Y Monthly)

3.50

52-Week Change

267.76%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

45.08M

Dividend Yield

0.00%

Float4

42.98M

% Held by Insiders

4.30%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

347.40M

Total Cash Per Share(mrq)

7.71

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.73%

Quick Ratio(mrq)

4.73%

Book Value Per Share(mrq)

8.52

Cash Flow

Operating Cash Flow Per Share(ytd)

2.49

Free Cash Flow(ytd)

122.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement